$AMED
AMEDISYS INC

2013 Q4 Form 10-Q Financial Statement

#000119312513438034 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $302.2M $301.3M $350.2M
YoY Change -13.71% -17.29% -5.43%
Cost Of Revenue $178.4M $175.2M $197.8M
YoY Change -9.81% -15.33% -1.98%
Gross Profit $123.8M $126.1M $152.4M
YoY Change -18.77% -19.89% -9.55%
Gross Profit Margin 40.97% 41.85% 43.52%
Selling, General & Admin $119.6M $119.8M $134.1M
YoY Change -10.81% -9.38% -2.69%
% of Gross Profit 96.61% 95.0% 87.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.700M $9.000M $10.10M
YoY Change -13.86% -9.09% -5.61%
% of Gross Profit 7.03% 7.14% 6.63%
Operating Expenses $124.4M $128.8M $143.9M
YoY Change -13.55% -9.3% -2.77%
Operating Profit -$600.0K -$154.2M $8.500M
YoY Change -107.06% -1104.08% -58.54%
Interest Expense -$1.400M $672.0K -$5.400M
YoY Change -74.07% -66.09% 217.65%
% of Operating Profit -63.53%
Other Income/Expense, Net -$1.000M $6.253M $3.600M
YoY Change -127.78% -493.02%
Pretax Income -$14.30M -$148.0M -$155.5M
YoY Change -90.8% -1174.68% -1296.15%
Income Tax -$5.300M -$56.93M -$34.30M
% Of Pretax Income
Net Earnings -$9.600M -$91.10M -$106.8M
YoY Change -91.01% -1020.2% -2583.72%
Net Earnings / Revenue -3.18% -30.24% -30.5%
Basic Earnings Per Share -$0.30 -$2.89 -$3.52
Diluted Earnings Per Share -$0.30 -$2.89 -$3.52
COMMON SHARES
Basic Shares Outstanding 32.46M shares 31.51M shares 30.94M shares
Diluted Shares Outstanding 31.51M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.30M $43.60M $14.50M
YoY Change 19.31% 11.51% -69.79%
Cash & Equivalents $17.30M $43.63M $14.55M
Short-Term Investments
Other Short-Term Assets $10.79M $9.819M $11.44M
YoY Change -5.73% -52.42% -53.55%
Inventory
Prepaid Expenses $10.67M $11.46M $10.63M
Receivables $111.1M $111.1M $169.2M
Other Receivables $5.700M $0.00 $0.00
Total Short-Term Assets $205.3M $234.4M $205.8M
YoY Change -0.25% 0.24% -11.3%
LONG-TERM ASSETS
Property, Plant & Equipment $159.0M $160.1M $156.7M
YoY Change 1.48% 6.05% 5.5%
Goodwill $208.9M $208.1M $209.6M
YoY Change -0.33% -43.37% -37.38%
Intangibles $36.70M $42.33M $47.00M
YoY Change -21.91% -18.53% -6.0%
Long-Term Investments $23.20M
YoY Change
Other Assets $26.28M $26.50M $18.65M
YoY Change 40.93% 56.23% -23.32%
Total Long-Term Assets $521.1M $520.2M $524.8M
YoY Change -0.7% -18.96% -16.2%
TOTAL ASSETS
Total Short-Term Assets $205.3M $234.4M $205.8M
Total Long-Term Assets $521.1M $520.2M $524.8M
Total Assets $726.4M $754.6M $730.6M
YoY Change -0.57% -13.83% -14.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.14M $24.36M $29.18M
YoY Change -30.97% 12.32% 14.52%
Accrued Expenses $57.57M $54.34M $54.86M
YoY Change 4.95% -15.7% -19.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $13.90M $34.90M $35.81M
YoY Change -61.18% -35.74% 5.66%
Total Short-Term Liabilities $312.4M $332.5M $204.8M
YoY Change 52.56% 43.65% -7.64%
LONG-TERM LIABILITIES
Long-Term Debt $33.00M $36.00M $66.90M
YoY Change -50.67% -46.95% -40.03%
Other Long-Term Liabilities $8.511M $8.297M $4.671M
YoY Change 82.21% 87.25% -3.73%
Total Long-Term Liabilities $41.51M $44.30M $71.57M
YoY Change -42.0% -38.72% -38.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $312.4M $332.5M $204.8M
Total Long-Term Liabilities $41.51M $44.30M $71.57M
Total Liabilities $353.9M $376.8M $276.4M
YoY Change 28.07% 24.04% -18.27%
SHAREHOLDERS EQUITY
Retained Earnings -$77.56M -$67.93M $18.62M
YoY Change -516.61% -154.16% -81.78%
Common Stock $467.9M $463.0M $450.8M
YoY Change 3.79% 3.75% 4.26%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.18M $18.08M $17.12M
YoY Change 6.19% 6.14% 8.54%
Treasury Stock Shares 875.0K shares 868.9K shares 789.9K shares
Shareholders Equity $372.2M $377.0M $452.3M
YoY Change
Total Liabilities & Shareholders Equity $726.4M $754.6M $730.6M
YoY Change -0.57% -13.83% -14.88%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income -$9.600M -$91.10M -$106.8M
YoY Change -91.01% -1020.2% -2583.72%
Depreciation, Depletion And Amortization $8.700M $9.000M $10.10M
YoY Change -13.86% -9.09% -5.61%
Cash From Operating Activities $8.400M $27.90M $15.60M
YoY Change -46.15% 27.98% -57.72%
INVESTING ACTIVITIES
Capital Expenditures -$12.70M -$9.400M -$16.10M
YoY Change -21.12% -21.67% 177.59%
Acquisitions
YoY Change
Other Investing Activities $1.800M -$1.900M -$3.600M
YoY Change -150.0% 375.0% -41.94%
Cash From Investing Activities -$11.00M -$11.30M -$19.80M
YoY Change -44.44% -8.13% 65.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $15.00M
YoY Change
Cash From Financing Activities -23.70M -3.100M -20.50M
YoY Change 15.61% -58.67% 225.4%
NET CHANGE
Cash From Operating Activities 8.400M 27.90M 15.60M
Cash From Investing Activities -11.00M -11.30M -19.80M
Cash From Financing Activities -23.70M -3.100M -20.50M
Net Change In Cash -26.30M 13.50M -24.70M
YoY Change 6.48% 575.0% -232.8%
FREE CASH FLOW
Cash From Operating Activities $8.400M $27.90M $15.60M
Capital Expenditures -$12.70M -$9.400M -$16.10M
Free Cash Flow $21.10M $37.30M $31.70M
YoY Change -33.44% 10.36% -25.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Interest Expense
InterestExpense
2523000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1054000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5296000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5675000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.06
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2069000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18650000
CY2012Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
5609000
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
377792000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
169172000
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11460000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
234410000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14545000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111149000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
11440000
CY2012Q4 us-gaap Liabilities
Liabilities
276362000
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
66904000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54855000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
205788000
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000896262
dei Trading Symbol
TradingSymbol
AMED
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
9819000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
452340000
CY2012Q4 us-gaap Minority Interest
MinorityInterest
1893000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43626000
CY2012Q4 us-gaap Assets
Assets
730595000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26501000
CY2013Q3 us-gaap Assets
Assets
754569000
CY2013Q3 us-gaap Goodwill
Goodwill
208126000
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42332000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160077000
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
68923000
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54340000
CY2013Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
34855000
amed Income Tax Benefit Expense For Care Centers Removed From Available For Sale
IncomeTaxBenefitExpenseForCareCentersRemovedFromAvailableForSale
200000
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32460456 shares
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Registrant Name
EntityRegistrantName
AMEDISYS INC
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
156709000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
47050000
CY2012Q4 us-gaap Goodwill
Goodwill
209594000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
0
amed Net Revenue For Care Centers Removed From Available For Sale
NetRevenueForCareCentersRemovedFromAvailableForSale
9200000
amed Income From Continuing Operations For Care Centers Removed From Available For Sale
IncomeFromContinuingOperationsForCareCentersRemovedFromAvailableForSale
400000
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
462962000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.89
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10631000
us-gaap Share Based Compensation
ShareBasedCompensation
4933000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
947165000
us-gaap Cost Of Services
CostOfServices
539582000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
229123000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-91778000
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-709000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67932000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.78
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
123734000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
754569000
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
79341000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4671000
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2013Q3 us-gaap Minority Interest
MinorityInterest
794000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
376998000
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32409474 shares
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-686000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31086619 shares
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
0
CY2013Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
0
CY2013Q3 amed Accrued Charge Related To Us Department Of Justice Settlement
AccruedChargeRelatedToUsDepartmentOfJusticeSettlement
150000000
us-gaap Operating Income Loss
OperatingIncomeLoss
-144890000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
40000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
332480000
CY2013Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
36000000
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8297000
CY2013Q3 us-gaap Liabilities
Liabilities
376777000
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
35807000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
204787000
CY2012Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2012Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
32000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
450792000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
17116000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18617000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
454233000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
730595000
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
18080000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2013Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
33000
CY2013Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23457000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20994000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
113154000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
789889 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31876508 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15601000
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125392000
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
868923 shares
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24926000
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33278397 shares
CY2012Q4 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
0
CY2013Q3 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
1348000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
24362000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
29175000
CY2012Q4 amed Accrued Charge Related To Us Department Of Justice Settlement
AccruedChargeRelatedToUsDepartmentOfJusticeSettlement
0
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
57008000
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
92804000
CY2013Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
83123000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
12531000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
32152000
us-gaap Costs And Expenses
CostsAndExpenses
1092055000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-139215000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-53454000
CY2012Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
46760000
CY2012Q3 amed Net Revenue For Care Centers Removed From Available For Sale
NetRevenueForCareCentersRemovedFromAvailableForSale
3600000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
548000
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-686000
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-90383000
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.06
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.72
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2036000
us-gaap Profit Loss
ProfitLoss
-87797000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1248000
us-gaap Net Income Loss
NetIncomeLoss
-86549000
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31505000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30055000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31102000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29741000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31505000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30423000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31102000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30068000 shares
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.87
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.34
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.72
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.85
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.87
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.34
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.86
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.08
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.89
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
455931000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-91069000
CY2013Q3 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
10471000
CY2013Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
40360000
CY2013Q3 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
3971000
CY2013Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
18000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5102000
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1653000
CY2013Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
73993000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-154292000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-148054000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-56962000
CY2013Q3 us-gaap Cost Of Services
CostOfServices
175483000
CY2013Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
301639000
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
354000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6238000
CY2013Q3 us-gaap Interest Expense
InterestExpense
687000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
348983000
CY2012Q3 us-gaap Cost Of Services
CostOfServices
206970000
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1284000
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
73000
CY2012Q3 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
9771000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
9922000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13769000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3332000
CY2012Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
390000
CY2012Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
10000
CY2012Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
78711000
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-442000
CY2012Q3 us-gaap Profit Loss
ProfitLoss
9995000
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-442000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2036000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
29081000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
25684000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
246155000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-85761000
CY2013Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-91092000
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
10437000
us-gaap Share Based Compensation
ShareBasedCompensation
6065000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
15788000
us-gaap Net Income Loss
NetIncomeLoss
23224000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
200000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1591000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
52000
CY2012Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
364343000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15360000
CY2012Q3 us-gaap Interest Expense
InterestExpense
1982000
CY2012Q3 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
5487000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14296000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2460000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4617000
us-gaap Costs And Expenses
CostsAndExpenses
1045876000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
135564000
us-gaap Profit Loss
ProfitLoss
23424000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
298000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1091000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40180000
us-gaap Operating Income Loss
OperatingIncomeLoss
44797000
us-gaap Interest Expense
InterestExpense
6058000
us-gaap Cost Of Services
CostOfServices
612929000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1090673000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
29375000
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
10364000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-84513000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2460000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
25884000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1808000
CY2013Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1451000
CY2012Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2013Q3 amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
150000000
CY2012Q3 amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
0
amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
150000000
amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-87797000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-86549000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-91778000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91069000
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9995000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9922000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23226000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
23426000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1239000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-53611000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
975000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45170000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1409000
CY2013Q3 amed Income Tax Benefit For Change In Statutory Tax Rate
IncomeTaxBenefitForChangeInStatutoryTaxRate
1500000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8111000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11198000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
93862000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
128000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28983000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
93000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
627000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35456000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
258000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2436000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
31856000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29325000
us-gaap Interest Paid
InterestPaid
2384000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3235000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
483000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1620000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
194000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10815000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32198000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53866000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1182000
us-gaap Interest Paid
InterestPaid
6896000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8599000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
155000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1066000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
145000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
239000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2875000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39106000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22515000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8744000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2934000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
25489000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8898000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1050000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31686000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48004000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16286000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12853000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
126000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
609000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30046000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28730000
us-gaap Notes Issued1
NotesIssued1
0
us-gaap Notes Issued1
NotesIssued1
2214000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
9732000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
25500000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3625000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-421000
us-gaap Pension Expense
PensionExpense
6200000
us-gaap Pension Expense
PensionExpense
7575000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
312000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
3725000
amed Intangible Assets Written Off
IntangibleAssetsWrittenOff
3828000
amed Intangible Assets Written Off
IntangibleAssetsWrittenOff
0
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
163000
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
105000
CY2013Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-500000
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
7300000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
25500000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40249000
CY2013Q3 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.5 pure
CY2013Q3 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.2 pure
CY2013Q3 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.5 pure
CY2012Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
4800000
us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:6pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and reporting policies conform with U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP. In preparing the </font><font style="font-family:Times New Roman;font-size:10pt;">unaudited condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> condensed</font><font style="font-family:Times New Roman;font-size:10pt;"> consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. </font></p>
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style='margin-top:6pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Reclassifications and Comparability</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"> </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reclassifications have been made to prior period's financial statements in order to conform to the current period's presentation</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">W</font><font style="font-family:Times New Roman;font-size:10pt;">e exited three home health care centers</font><font style="font-family:Times New Roman;font-size:10pt;"> during 2012, and have </font><font style="font-family:Times New Roman;font-size:10pt;">committed to a plan to divest </font><font style="font-family:Times New Roman;font-size:10pt;">approximately </font><font style="font-family:Times New Roman;font-size:10pt;">28</font><font style="font-family:Times New Roman;font-size:10pt;"> care centers. In accordance with applicable accounting guidance</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> the results of operations for these care centers are presented in discontinued operations in our condensed consolidated financial statements. See Note </font><font style="font-family:Times New Roman;font-size:10pt;">3 for additional information regarding our discontinued operations.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In addition</font><font style="font-family:Times New Roman;font-size:10pt;"> during 2013</font><font style="font-family:Times New Roman;font-size:10pt;">, w</font><font style="font-family:Times New Roman;font-size:10pt;">e have consolidated </font><font style="font-family:Times New Roman;font-size:10pt;">32</font><font style="font-family:Times New Roman;font-size:10pt;"> care centers with care centers servicing the same market</font><font style="font-family:Times New Roman;font-size:10pt;">s,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">which may affect the comparability of our operating results.</font></p><p style='margin-top:6pt; margin-bottom:0pt'>&#160;</p>
CY2013Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
37 States
CY2013Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1300000
CY2013Q3 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
8800000
CY2013Q2 amed Number Of Care Centers Sold
NumberOfCareCentersSold
3 Agencies
amed Number Of Care Centers Consolidated
NumberOfCareCentersConsolidated
32 Agencies
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
CY2012 amed Number Of Care Centers Closed
NumberOfCareCentersClosed
3 Agencies
CY2013Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.84 pure
CY2012Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.82 pure
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.84 pure
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.82 pure
amed Number Of Care Centers Available For Sale
NumberOfCareCentersAvailableForSale
28 Agencies
CY2013Q3 us-gaap Cost Method Investments
CostMethodInvestments
5000000
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.1 pure
amed Episodes Of Progress That Begin During Reporting Period
EpisodesOfProgressThatBeginDuringReportingPeriod
60
CY2013Q3 amed Estimated Amount Due Back To Medicare In Other Accrued Liabilities
EstimatedAmountDueBackToMedicareInOtherAccruedLiabilities
3000000
CY2012Q4 amed Estimated Amount Due Back To Medicare In Other Accrued Liabilities
EstimatedAmountDueBackToMedicareInOtherAccruedLiabilities
4800000
amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
9100000
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
7400000
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.70 pure
CY2012 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.68 pure
CY2013Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
1.00 pure
CY2012Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
1.00 pure
CY2012Q3 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
2700000
CY2013Q3 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
2500000
amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.6 pure
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.5 pure
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2013Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
70900000
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.395 pure
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-1700000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16000 shares
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
25900000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-3400000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-1400000
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
682000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
196000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
20000 shares
CY2013Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
CY2012Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
348000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
311000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
640000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
233000 shares
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
34400000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-4200000
CY2013Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1200000
CY2012Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
11300000
CY2012Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-300000
CY2012Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-700000
CY2013Q2 amed Number Of Care Centers Included In Divestiture Plan
NumberOfCareCentersIncludedInDivestiturePlan
50 Agencies
CY2013Q2 amed Number Of Care Centers Consolidated
NumberOfCareCentersConsolidated
19 Agencies
CY2013Q2 amed Number Of Care Centers Available For Sale
NumberOfCareCentersAvailableForSale
34 Agencies
CY2013Q3 amed Number Of Care Centers Removed From Available For Sale
NumberOfCareCentersRemovedFromAvailableForSale
6 Agencies
amed Net Revenue For Care Centers Removed From Available For Sale
NetRevenueForCareCentersRemovedFromAvailableForSale
10900000
amed Income Loss Before Income Taxes For Care Centers Removed From Available For Sale
IncomeLossBeforeIncomeTaxesForCareCentersRemovedFromAvailableForSale
1400000
amed Income Tax Benefit Expense For Care Centers Removed From Available For Sale
IncomeTaxBenefitExpenseForCareCentersRemovedFromAvailableForSale
500000
amed Income From Continuing Operations For Care Centers Removed From Available For Sale
IncomeFromContinuingOperationsForCareCentersRemovedFromAvailableForSale
900000
CY2013Q3 amed Net Revenue For Care Centers Removed From Available For Sale
NetRevenueForCareCentersRemovedFromAvailableForSale
2800000
CY2013Q3 amed Income From Continuing Operations For Care Centers Removed From Available For Sale
IncomeFromContinuingOperationsForCareCentersRemovedFromAvailableForSale
0
CY2012Q3 amed Income From Continuing Operations For Care Centers Removed From Available For Sale
IncomeFromContinuingOperationsForCareCentersRemovedFromAvailableForSale
300000
CY2013Q3 amed Income Tax Benefit Expense For Care Centers Removed From Available For Sale
IncomeTaxBenefitExpenseForCareCentersRemovedFromAvailableForSale
0
CY2013Q3 amed Income Loss Before Income Taxes For Care Centers Removed From Available For Sale
IncomeLossBeforeIncomeTaxesForCareCentersRemovedFromAvailableForSale
0
CY2012Q3 amed Income Tax Benefit Expense For Care Centers Removed From Available For Sale
IncomeTaxBenefitExpenseForCareCentersRemovedFromAvailableForSale
100000
CY2012Q3 amed Income Loss Before Income Taxes For Care Centers Removed From Available For Sale
IncomeLossBeforeIncomeTaxesForCareCentersRemovedFromAvailableForSale
400000
amed Income Loss Before Income Taxes For Care Centers Removed From Available For Sale
IncomeLossBeforeIncomeTaxesForCareCentersRemovedFromAvailableForSale
600000
CY2013Q3 amed Number Of Care Centers Sold
NumberOfCareCentersSold
0 Agencies
amed Number Of Care Centers Sold
NumberOfCareCentersSold
3 Agencies
CY2013Q3 us-gaap Long Term Debt
LongTermDebt
70900000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
102700000
CY2013Q3 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
1.7 pure
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36000000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
66900000
CY2013Q3 amed Total Leverage Ratio
TotalLeverageRatio
2.7 pure
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
CY2013Q3 amed Insurance Proceeds For Reimbursement Of Legal Fees
InsuranceProceedsForReimbursementOfLegalFees
5500000
amed Medicare Revenue
MedicareRevenue
4000000
amed Interest Rate On Us Department Of Justice Settlement
InterestRateOnUsDepartmentOfJusticeSettlement
0.0225 pure
amed Payment Upon Execution Of Us Department Of Justice Settlement
PaymentUponExecutionOfUsDepartmentOfJusticeSettlement
115000000
amed Final Payment Of Us Department Of Justice Settlement
FinalPaymentOfUsDepartmentOfJusticeSettlement
35000000
amed Period Of Time For Final Payment Of Us Department Of Justice Settlement
PeriodOfTimeForFinalPaymentOfUsDepartmentOfJusticeSettlement
P6M
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
357900000
CY2013Q3 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
116000000
CY2012Q3 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
126700000
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
387800000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20000000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
400000

Files In Submission

Name View Source Status
0001193125-13-438034-index-headers.html Edgar Link pending
0001193125-13-438034-index.html Edgar Link pending
0001193125-13-438034.txt Edgar Link pending
0001193125-13-438034-xbrl.zip Edgar Link pending
amed-20130930.xml Edgar Link completed
amed-20130930.xsd Edgar Link pending
amed-20130930_cal.xml Edgar Link unprocessable
amed-20130930_def.xml Edgar Link unprocessable
amed-20130930_lab.xml Edgar Link unprocessable
amed-20130930_pre.xml Edgar Link unprocessable
d625962d10q.htm Edgar Link pending
d625962dex1011.htm Edgar Link pending
d625962dex1012.htm Edgar Link pending
d625962dex102.htm Edgar Link pending
d625962dex311.htm Edgar Link pending
d625962dex312.htm Edgar Link pending
d625962dex321.htm Edgar Link pending
d625962dex322.htm Edgar Link pending
d625962dex424.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g625962g70s10.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending